Rehabilitation in cancer survivors: Interaction between lifestyle and physical activity

European Journal of Inflammation

Volumn 6, Issue 3, 2008, Pages 99-104

  Saggini, Raoul ^a   Calvani, M ^a   Bellomo, R G ^a   Saggini, A ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cancer survival; Inflammation; Quality of life; Rehabilitation

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARNITINE; CORTICOSTEROID; CYTOKINE RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN INHIBITOR; PSYCHOSTIMULANT AGENT; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR INHIBITOR; VITAMIN D;

ADJUVANT THERAPY; BEHAVIOR THERAPY; BODY POSTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVOR; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISTRESS SYNDROME; DRUG EFFICACY; DRUG SAFETY; DRUG SYNTHESIS; EDITORIAL; ENDURANCE; ENERGY EXPENDITURE; EXERCISE; FATIGUE; FRAGILITY FRACTURE; FUNCTIONAL DISEASE; GENETIC PREDISPOSITION; HEALTH BEHAVIOR; HEALTH HAZARD; HIGH RISK PATIENT; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MALIGNANT NEOPLASTIC DISEASE; MEDICAL CARE; MEDICAL SPECIALIST; METABOLIC SYNDROME X; MUSCLE MASS; MUSCLE STRENGTH; OBESITY; ONCOLOGY; OSTEOPOROSIS; OVERALL SURVIVAL; PATIENT CARE; PHYSICAL ACTIVITY; PHYSICAL DISEASE; QUALITY OF LIFE; REHABILITATION CARE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECOND CANCER; SIDE EFFECT; SURVIVAL TIME; WEIGHT GAIN; WELLBEING;

EID: 58149489309     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X0800600301     Document Type: Editorial

References (32)

1. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005; 23(24):5814-30.
2. Prouty D, Ward-Smith P, Hutto CJ. The lived experience of adult survivors of childhood cancer. J Pediatr Oncol Nurs 2006; 23(3):143-51.
3. Kayacan O, Karnak D, Beder S, Gullu E, Tutkak H, Senler FC, Koksal D. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients: Am J Clin Oncol 2006; 29(4):328-35.
4. Strasser F, Luftner D, Possinger K, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol 2006; 24(21):3394-400.
5. Uomo G, Gallucci F, Rabitti PG. Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management. JOP 2006; 7(2):157-62.
6. Demark-Wahnefried W, Kenyon AJ, Eberle P, Skye A, Kraus WE. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol 2002; 4(1):44-49.
7. Heber D, Ingles S, Ashley JM, et al. Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Amer J Clin Nutr 1996; 64:S472-7.
8. Roubenoff R, Parise H, Payette HA, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med 2003; 115:429-35.
9. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med 2001; 137: 231-43.
10. McLeod N, Huynh CC, Rashid P. Osteoporosis from androgen deprivation therapy in prostate cancer treatment. Aust Fam Physician 2006; 35(4):243-5.
11. Demark-Wahnefried L, Bercedis BL, Winer EP, Marks L, Aziz NM, Marcom PK, Blackwell K, Rimer BK. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001; 19:2381-9.
12. Yoshikawa T, Noguchi Y, Doi C, et al. Insulin resistance in patients with cancer: Relationships with tumor site, rumor stage, body-weight loss, acute-phase response, and energy expenditure. Nutrition 2001; 17:590-3.
13. Ludwig S, Shen GX. Statins for diabetic cardiovascular complications. Curr Vasc Pharmacol 2006; 4(3):245-51.
14. Haffner SM, Ruilope L, Dahlof B, Abadie E, Kupfer S, Zannad F. Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials. J Cardiovasc Pharmacol 2006; 47(3):469-75.
15. Riboulet-Chavey A, Pierron A, Durand I, Murdaca J, Giudicelli J, Van Obberghen E. Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes 2006; 55(5):1289-99.
16. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006; 13(2):279-92.
17. Twiss JJ, Waltman N, Ott CD, Gross GJ, Lindsey AM, Moore TE. Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract 2001; 13(6):276-84.
18. Davis MP, Khoshknabi D, Yue GH. Management of fatigue in cancer patients. Curr Pain Headache Rep 2006; 10(4):260-9.
19. Mastrangelo F, Scioletti P, Tranasi M, et al. Dentin sialophosphoprotein expression during human matrix development. J Biol Regul Homeost Agents 2007; 21:33-40.
20. Orciani M, Trubiani O, Cavaletti G, Guarnieri S, Salvolini E, Tredici G, Di Primio R. Expression of CD38 in human neuroblastoma SH-SY5Y cells. Int J Immunopathol Pharmacol 2008; 21:97-106.
21. McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006; 175(1):34-41.
22. Basen-Engquist K, Taylor CL, Rosenblum C, et al. Randomized pilot test of a lifestyle physical activity intervention for breast cancer survivors. Patient Educ Couns 2006; 64(1-3):225-34.
23. Gammon MD, John EM, Britton JA. Recreational and occupational physical activities and risk of breast cancer. J Natl Cancer Inst 1998, 90:100-117.
24. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005; 293:2479-86.
25. Wu AH, Pike MC, Stram DO. Meta-analysis: Dietary fat intake, serum estrogen levels and the risk of breast cancer. J Natl Cancer Inst 1999; 91:529-34.
26. Aziz NM. 2002. Long-term survivorship: late effects. In: Principles and Practice of Palliative Care and Supportive Oncology, 2nd ed. (Berger AM, Portenoy RK & Weissman DE, eds.), Lippincott Williams & Wilkins, Philadelphia, PA, pp. 1019-1033.
27. Li Q, Morimoto K, Kobayashi M, et al. Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol 2008; 21:117-28.
28. Speranza L, Grilli A, Patruno A, et al. Plasmatic markers of muscular stress in isokinetic exercise. J Biol Regul Homeost Agents 2007; 21:23-32.
29. Issurin VB. Vibrations and their applications in sport. A review J Sports Med Phys Fitness. 2005; 45(3): 324-36.
30. Johannsen L, Akermann H, Karnath H-O. Lasting amelioration of spatial neglect by treatment with neck muscle vibration even without concurrent training. J Rehabilitation Medicine 2003; 35:249-253.
31. Rosenkranz K, Rothwell JC. The effect of sensory input and attention on the sensorimotor organization of the hand area of the human motor cortex. J Physiol 2004; 561(1):307-20.
32. Saggini R, Scuderi N, Bellomo RG, Dessy LA, Cancelli P, Iodice P. Selective development of muscular force in rehabilitative context. Eura Medicophys 2006; 42(S3):69-73.